+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dutasteride Drug Market - Global Forecast 2025-2030- Product Image
Dutasteride Drug Market - Global Forecast 2025-2030- Product Image
Sale

Dutasteride Drug Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6130522
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Dutasteride’s market landscape is advancing rapidly, catalyzed by evolving clinical protocols, regulatory reforms, and digital integration. Senior leaders are now navigating a complex yet opportunity-rich environment marked by shifting prescriber patterns and supply chain recalibrations.

Market Snapshot: Dutasteride Market Opportunities and Trends

The global dutasteride market is witnessing transformational shifts, highlighted by broad clinical adoption across benign prostatic hyperplasia management and emerging off-label applications. Dual inhibition of 5α-reductase enzyme types has set apart dutasteride’s symptomatic efficacy and long-term tolerability. Regulatory evolution, notably post-approval surveillance demands, is fostering greater investment in compliance systems and data transparency. Meanwhile, digital health solutions and telemedicine are streamlining patient engagement and supporting therapeutic outcomes. Diversification of supply networks intensifies as companies seek to mitigate the effects of tariff revisions and regional market volatility, especially with tariff adjustments impacting the United States from 2025 onward.

Scope & Segmentation: Dutasteride Ecosystem Structure

This report offers comprehensive segmentation for granular strategic analysis across the dutasteride value chain:

  • Product Types: Branded, Generic
  • Formulations: Soft Gel Capsule, Tablet
  • Distribution Channels: Hospital Pharmacy (Private Hospital, Public Hospital), Online Pharmacy (Manufacturer Website, Third Party Marketplace), Retail Pharmacy (Chain Pharmacy, Independent Pharmacy)
  • Dosage Strength: 0.5 Mg
  • End Users: Clinics, Home Care, Hospitals
  • Regional Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, and others), Asia-Pacific (including China, India, Japan, Australia, and more)
  • Key Companies: GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Viatris Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Lupin Limited, Torrent Pharmaceuticals Ltd.

These segments enable focused evaluations on procurement strategies, manufacturing agility, and regional regulatory adaptation.

Key Takeaways: Actionable Strategic Insights

  • Dutasteride is a preferred pharmacologic option for benign prostatic hyperplasia due to its dual enzyme inhibition mechanism, which targets the hormonal basis of prostate enlargement.
  • Recent regulatory recalibrations, coupled with reinforced pharmacovigilance, drive manufacturers to adopt real-time analytics and electronic batch-recording systems to meet compliance and accelerate market entry.
  • Tariff adjustments in the United States prompt companies to reexamine global procurement, near-shoring, and alternative vendor strategies, with distributors renegotiating contracts to respond to shifting fiscal risk.
  • Growth in telemedicine and digital platforms is reshaping patient engagement, blending in virtual consultations and ongoing monitoring to improve adherence to dutasteride therapies.
  • Dutasteride’s versatility is evidenced in combination therapy trials and potential off-label use for androgenetic alopecia, enhancing its value in individualized, patient-centric treatment pathways.
  • Collaborative registries and real-world data collection inform targeting of patient subpopulations and guide differentiated communication strategies for stakeholders.

Dutasteride Market Tariff Impact

The 2025 United States tariff revisions introduce incremental duties on select pharmaceutical imports, directly affecting the cost structure of dutasteride’s supply chain. Manufacturers are diversifying procurement models and exploring near-shoring to maintain margin stability. Distributors are also adopting sophisticated forecasting and inventory optimization approaches to minimize tariff-driven volatility. These steps are crucial for protecting commercial viability and maintaining patient accessibility, prompting stakeholder engagement with trade associations to pursue exemptions and offset financial exposure.

Methodology & Data Sources for Dutasteride Market Analysis

Analysis of the dutasteride market draws on primary research—targeted interviews with urology experts, pharmacists, payers, and supply chain executives—combined with secondary sources such as clinical registries, regulatory filings, and peer-reviewed studies. Data integrity was assured through triangulation, thematic coding, and subject matter expert review, resulting in robust, strategically relevant insights.

Why This Report Matters for Senior Decision-Makers

  • Enables C-suite leaders to anticipate regulatory and supply chain disruptions while optimizing global and regional market strategies for dutasteride.
  • Delivers actionable intelligence on patient-centric innovation, digital health trends, and competitive positioning to improve operational resilience and stakeholder engagement.

Conclusion

Stakeholders navigating the dutasteride market face a landscape shaped by clinical innovation, supply chain evolution, and region-specific strategies. With future-oriented insights, leaders can confidently advance growth and maximize therapeutic value for targeted patient populations.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising off-label adoption of dutasteride for treatment of female pattern hair loss in dermatology clinics
5.2. Expansion of generic dutasteride portfolios after patent expiry reshaping pricing and competitive landscape in key markets
5.3. Increasing uptake of combination therapy regimens integrating dutasteride with alpha blockers to enhance benign prostatic hyperplasia management
5.4. Surge in telemedicine-driven dutasteride prescriptions boosted by virtual urology platforms and online patient engagement strategies
5.5. Development of novel topical dutasteride delivery systems aimed at minimizing systemic exposure and improving patient adherence
5.6. Supply chain bottlenecks from active pharmaceutical ingredient shortages affecting global dutasteride availability and driving regional price volatility
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Dutasteride Drug Market, by Product Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Dutasteride Drug Market, by Formulation
9.1. Introduction
9.2. Soft Gel Capsule
9.3. Tablet
10. Dutasteride Drug Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.2.1. Private Hospital
10.2.2. Public Hospital
10.3. Online Pharmacy
10.3.1. Manufacturer Website
10.3.2. Third Party Marketplace
10.4. Retail Pharmacy
10.4.1. Chain Pharmacy
10.4.2. Independent Pharmacy
11. Dutasteride Drug Market, by Dosage Strength
11.1. Introduction
11.2. 0.5 Mg
12. Dutasteride Drug Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Home Care
12.4. Hospitals
13. Americas Dutasteride Drug Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Dutasteride Drug Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Dutasteride Drug Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. GlaxoSmithKline plc
16.3.2. Teva Pharmaceutical Industries Ltd.
16.3.3. Sandoz International GmbH
16.3.4. Viatris Inc.
16.3.5. Sun Pharmaceutical Industries Ltd.
16.3.6. Cipla Ltd.
16.3.7. Dr. Reddy’s Laboratories Ltd.
16.3.8. Aurobindo Pharma Limited
16.3.9. Lupin Limited
16.3.10. Torrent Pharmaceuticals Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DUTASTERIDE DRUG MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DUTASTERIDE DRUG MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DUTASTERIDE DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DUTASTERIDE DRUG MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. DUTASTERIDE DRUG MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. DUTASTERIDE DRUG MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. DUTASTERIDE DRUG MARKET: RESEARCHAI
FIGURE 26. DUTASTERIDE DRUG MARKET: RESEARCHSTATISTICS
FIGURE 27. DUTASTERIDE DRUG MARKET: RESEARCHCONTACTS
FIGURE 28. DUTASTERIDE DRUG MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DUTASTERIDE DRUG MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DUTASTERIDE DRUG MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DUTASTERIDE DRUG MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY SOFT GEL CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY SOFT GEL CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY THIRD PARTY MARKETPLACE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY THIRD PARTY MARKETPLACE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY 0.5 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY 0.5 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DUTASTERIDE DRUG MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS DUTASTERIDE DRUG MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES DUTASTERIDE DRUG MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 95. CANADA DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. CANADA DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. CANADA DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 98. CANADA DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 99. CANADA DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. CANADA DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. CANADA DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 102. CANADA DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 103. CANADA DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 104. CANADA DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 105. CANADA DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 106. CANADA DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 107. CANADA DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 108. CANADA DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 109. CANADA DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. CANADA DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. MEXICO DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. MEXICO DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. MEXICO DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 114. MEXICO DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 115. MEXICO DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. MEXICO DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. MEXICO DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 118. MEXICO DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 119. MEXICO DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 120. MEXICO DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 121. MEXICO DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 122. MEXICO DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 123. MEXICO DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 124. MEXICO DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 125. MEXICO DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. MEXICO DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA DUTASTERIDE DRUG MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. GERMANY DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. GERMANY DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. GERMANY DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 196. GERMANY DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 197. GERMANY DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. GERMANY DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. GERMANY DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 200. GERMANY DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 201. GERMANY DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 202. GERMANY DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 203. GERMANY DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 204. GERMANY DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 205. GERMANY DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 206. GERMANY DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 207. GERMANY DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. GERMANY DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. FRANCE DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. FRANCE DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. FRANCE DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 212. FRANCE DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 213. FRANCE DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. FRANCE DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. FRANCE DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 216. FRANCE DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 217. FRANCE DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 218. FRANCE DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 219. FRANCE DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 220. FRANCE DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 221. FRANCE DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 222. FRANCE DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 223. FRANCE DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. FRANCE DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. ITALY DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. ITALY DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. ITALY DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 244. ITALY DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 245. ITALY DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. ITALY DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. ITALY DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 248. ITALY DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 249. ITALY DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 250. ITALY DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 251. ITALY DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 252. ITALY DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 253. ITALY DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 254. ITALY DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 255. ITALY DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. ITALY DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. SPAIN DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 258. SPAIN DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 259. SPAIN DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 260. SPAIN DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 261. SPAIN DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. SPAIN DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. SPAIN DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 264. SPAIN DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 265. SPAIN DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 266. SPAIN DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 267. SPAIN DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 268. SPAIN DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 269. SPAIN DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 270. SPAIN DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 271. SPAIN DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. SPAIN DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. SAUDI ARABIA DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 292. SAUDI ARABIA DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. SAUDI ARABIA DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. SOUTH AFRICA DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. SOUTH AFRICA DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 308. SOUTH AFRICA DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. SOUTH AFRICA DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. DENMARK DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 322. DENMARK DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 323. DENMARK DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 324. DENMARK DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 325. DENMARK DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. DENMARK DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. DENMARK DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 328. DENMARK DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 329. DENMARK DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 330. DENMARK DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 331. DENMARK DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 332. DENMARK DUTASTERIDE DRUG MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 333. DENMARK DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 334. DENMARK DUTASTERIDE DRUG MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 335. DENMARK DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 336. DENMARK DUTASTERIDE DRUG MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 337. NETHERLANDS DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 338. NETHERLANDS DUTASTERIDE DRUG MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 339. NETHERLANDS DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 340. NETHERLANDS DUTASTERIDE DRUG MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 341. NETHERLANDS DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 342. NETHERLANDS DUTASTERIDE DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 343. NETHERLANDS DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 344. NETHERLANDS DUTASTERIDE DRUG MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 345. NETHERLANDS DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 346. NETHERLANDS DUTASTERIDE DRUG MARKET SIZE, BY ONLINE PHARMACY, 202

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Dutasteride Drug market report include:
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Viatris Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Aurobindo Pharma Limited
  • Lupin Limited
  • Torrent Pharmaceuticals Ltd.

Related Topics

Related Reports

Mini Softgel Capsule Market - Global Forecast 2025-2030 - Product Image

Mini Softgel Capsule Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
OTC Eye Drops & Lubricants Drugs Market - Global Forecast 2025-2030 - Product Image

OTC Eye Drops & Lubricants Drugs Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Pharmaceutical Excipients Market by Product ((Organic (Oleochemicals, Cellulose, Glycols), Inorganic)), Functionality (Fillers & Diluents, Binders, Lubricants), Formulation (Oral, Parenteral), Functionality Application (Stabilizers) - Global Forecast to 2030 - Product Image

Pharmaceutical Excipients Market by Product ((Organic (Oleochemicals, Cellulose, Glycols), Inorganic)), Functionality (Fillers & Diluents, Binders, Lubricants), Formulation (Oral, Parenteral), Functionality Application (Stabilizers) - Global Forecast to 2030

  • Report
  • 633 Pages
  • Global
From
Pharmaceutical Lipid-Based Excipients Market Size, Share & Trends Analysis Report by Excipient Type, Product Applications, Disease Application, Industry Application, Age Group, End-Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Pharmaceutical Lipid-Based Excipients Market Size, Share & Trends Analysis Report by Excipient Type, Product Applications, Disease Application, Industry Application, Age Group, End-Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 400 Pages
  • Global
From
U.S. Active Pharmaceutical Ingredients CDMO Market Size, Share & Trends Analysis Report By Product (Traditional API, HP-API, ADC), By Synthesis, By Drug, By Workflow, By Application, And Segment Forecasts, 2025 - 2030 - Product Image

U.S. Active Pharmaceutical Ingredients CDMO Market Size, Share & Trends Analysis Report By Product (Traditional API, HP-API, ADC), By Synthesis, By Drug, By Workflow, By Application, And Segment Forecasts, 2025 - 2030

  • Report
  • 80 Pages
  • United States
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.